McGinn, O. J., Krishnan, S., Bourquin, J., Sapra, P., Dempsey, C., Saha, V., & Stern, P. L. (2017). Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia. Haematologica.

McGinn, Owen J., Shekhar Krishnan, Jean-Pierre Bourquin, Puja Sapra, Clare Dempsey, Vaskar Saha, and Peter L. Stern. "Targeting the 5T4 Oncofetal Glycoprotein With an Antibody Drug Conjugate (A1mcMMAF) Improves Survival in Patient-derived Xenograft Models of Acute Lymphoblastic Leukemia." Haematologica 2017.

McGinn, Owen J., et al. "Targeting the 5T4 Oncofetal Glycoprotein With an Antibody Drug Conjugate (A1mcMMAF) Improves Survival in Patient-derived Xenograft Models of Acute Lymphoblastic Leukemia." Haematologica 2017.